EmpoweredNews wrote today about the FDA approval Allergan earned to expand the uses of the Lap-Band to patients with a lower BMI than previously allowed. Their article titled Lap-Band Wins Approval from FDA, Trumps Weight Loss Drugs says…
“In its decision, the FDA said the product “may have a potential to significantly impact” obesity-related medical conditions, citing a study of 143 patients that demonstrated “statistically significant improvement” within a year of surgery. The review noted that the data shows those patients’ weights were stable even beyond 12 months.
Meanwhile, obesity and weight loss drugs are not having much success with the FDA. Takeda Pharmaceutical and Orexigen Therapeutics’ Contrave drug was rejected by the agency on safety concerns.”
Read the entire article here.
In the News